Artiva Biotherapeutics, Inc. ARTV Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s net income?
- Artiva Biotherapeutics, Inc. (ARTV) reported net income of -$23.52M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s net income changed year-over-year?
- Artiva Biotherapeutics, Inc.'s net income decreased by 15.8% year-over-year, from -$20.31M to -$23.52M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s net income?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s net income has grown at a 70.9% compound annual growth rate (CAGR), from -$28.72M to -$83.87M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.